MarketFriction

Amrutanjan Health Care Ltd

NSE AMRUTANJAN · BSE 590006 · Pharmaceuticals
₹513.20 -0.30%
NSE close2026-10-01
52 week range476.50 - 760.15
Market cap₹1,465 Cr.
P/E23.6
Price band 20% Delivery 57.4%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales99.31116.99127.0683.74109.92122.75135.4194.05117.70141.04149.77102.97
Expenses92.4795.42110.8280.1996.3299.40117.7185.61101.18115.87124.2296.73
Operating Profit6.8421.5716.243.5513.6023.3517.708.4416.5225.1725.556.24
OPM %6.89%18.44%12.78%4.24%12.37%19.02%13.07%8.97%14.04%17.85%17.06%6.06%
Other Income3.953.764.954.454.054.364.824.434.302.87-2.881.78
Interest0.030.050.050.060.060.060.040.050.050.050.050.04
Depreciation1.551.581.531.591.651.661.621.531.561.621.611.92
Profit before tax9.2123.7019.616.3515.9425.9920.8611.2919.2126.3721.016.06
Tax %25.62%26.41%30.34%27.24%25.97%25.93%27.23%26.40%27.33%26.20%22.94%28.05%
Net Profit6.8517.4513.664.6211.8019.2515.188.3113.9619.4516.194.37
EPS in Rs2.376.044.721.604.086.665.252.874.836.735.601.51
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales174207220253261333406380421452503511
Expenses143178192222231258326335369394427438
Operating Profit322928313175804552587673
OPM %18%14%13%12%12%22%20%12%12%13%15%14%
Other Income67878111515161896
Interest000001100000
Depreciation323344456767
Profit before tax353433353482915462697873
Tax %35%35%39%29%27%25%26%26%27%26%26%
Net Profit222220252561674045515854
EPS in Rs7.687.476.848.398.5820.9322.9913.6315.5517.5820.0318.67
Dividend Payout %25%26%22%26%24%20%20%34%30%26%24%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth11%9%10%11%
Compounded Profit Growth12%1%17%14%
Stock Price CAGR9%-10%-6%-30%
Return on Equity19%18%17%18%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital333333333333
Reserves102118113126143156213262288286324367
Borrowings002002111222
Other Liabilities2528343842445784707793137
Total Liabilities130149152166188205274350362367421509
Fixed Assets132227282626232849504951
CWIP4110002171216106
Investments1410108181818135003
Other Assets100116115131144161232291307315356349
Total Assets130149152166188205274350362367421509
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity19218192118915220285136
Cash from Investing Activity-51-0-8-11-14-88-36-219-31-21
Cash from Financing Activity-12-11-5-9-7-12-7-17-15-48-13-14
Net Cash Flow212323-7-4-13-161
Free Cash Flow132051819168929112115-19
CFO/OP114%104%77%105%101%95%146%96%81%86%118%72%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days625551464737193432424544
Inventory Days444444404574455358504556
Days Payable465111010292981061229596113106
Cash Conversion Cycle6148-15-16013-41-35-6-5-23-6
Working Capital Days42457626307028921171739994
ROCE %26%29%28%25%25%23%44%38%19%21%22%25%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters50.59%50.59%50.59%50.58%46.52%46.52%46.52%46.52%46.52%46.52%46.52%46.52%
FIIs0.75%0.80%1.38%1.55%2.34%2.30%2.30%2.41%2.38%2.27%2.17%2.44%
DIIs7.10%7.24%7.29%7.32%10.60%11.13%11.41%12.70%12.90%13.00%12.66%12.29%
Public41.39%41.19%40.66%40.47%40.50%40.01%39.75%38.34%38.16%38.18%38.61%38.72%
Others0.18%0.18%0.07%0.07%0.04%0.04%0.04%0.04%0.04%0.04%0.04%0.04%
No. of Shareholders72,00268,40462,66457,16954,53653,85651,67449,43147,95446,67545,80545,135

Fundamentals

Market Cap₹ 1,465 Cr.
Current Price₹ 505
Stock P/E23.6
Book Value₹ 128
ROCE24.8 %
ROE18.4 %
Dividend Yield0.97 %
Face Value₹ 1.00
Compounded Sales Growth (TTM)11%
Compounded Profit Growth (TTM)14%
Standalone figures.
Valuation
Market capRs 1,484 Cr
Enterprise valueRs 1,452 Cr
P/E (TTM)27.49x
Price to book4.01x
Price to sales2.90x
EV / EBITDA18.25x
EV / EBIT19.94x
EV / sales2.84x
Price to cash flow41.25x
Earnings yield3.64%
Dividend yield0.95%
P/E, 3-year average33.87x
P/B, 3-year average5.28x
P/E, 5-year average35.69x
P/B, 5-year average6.08x
Profitability
Operating margin (excl. other income)15.10%
Operating margin (incl. other income)16.83%
EBITDA margin15.55%
Pre-tax margin14.20%
Net profit margin10.55%
Net margin, latest quarter4.24%
ROE16.62%
ROCE22.34%
ROA12.45%
ROE, 3-year average16.23%
ROCE, 3-year average22.05%
ROA, 3-year average12.56%
ROE, 5-year average18.19%
ROCE, 5-year average24.65%
ROA, 5-year average14.08%
ROIC (approx.)15.99%
Tax rate25.64%
Other income / net worth2.36%
Growth
Sales growth (latest year)11.23%
Profit growth (latest year)13.95%
Sales CAGR, 3 years9.80%
Sales CAGR, 5 years8.59%
Profit CAGR, 3 years13.29%
Profit CAGR, 5 years-1.09%
Sales growth QoQ-31.25%
Profit growth QoQ-73.01%
Sales growth YoY (latest quarter)9.48%
Profit growth YoY (latest quarter)-47.41%
Per share
EPS (TTM)Rs 18.67
EPS (latest year)Rs 20.03
EPS (latest quarter)Rs 1.51
EPS, 3-year averageRs 17.72
EPS, 5-year averageRs 17.96
Book value per shareRs 128.06
Sales per shareRs 176.92
Cash flow per shareRs 12.44
Free cash flow per shareRs -6.57
Dividend per share (latest year)Rs 4.90
Dividend per share, 3-year averageRs 4.70
Dividend per share, 5-year averageRs 4.66
Dividends
Dividend payout24.45%
Dividend payout, 3-year average26.72%
Dividend payout, 5-year average26.77%
Efficiency
Asset turnover0.99x
Fixed asset turnover9.81x
Inventory turnover6.97x
Inventory days52 days
Debtor days44 days
Debtors turnover8.29x
Creditor days106 days
Cash conversion cycle-6 days
Working capital days94 days
Leverage
Total debtRs 2 Cr
Cash and bankRs 33 Cr
Net debtRs -32 Cr
Debt to equity0.00x
Net debt / EBITDA-0.40x
Interest coverage383.37x
Current ratio (filing 2026-03-31)2.31x
Quick ratio (filing 2026-03-31)2.02x
Trade payables (filing 2026-03-31)Rs 71 Cr
Owners' fund to total sources72.75%
Debt to assets0.35%
Cash flow
Cash from Operating Activity (latest year)Rs 36 Cr
Cash from Investing Activity (latest year)Rs -21 Cr
Cash from Financing Activity (latest year)Rs -14 Cr
Net Cash Flow (latest year)Rs 1 Cr
Free cash flow (latest year)Rs -19 Cr
FCFE (approx.: FCF + change in debt)Rs -19 Cr
Cash from ops / profit, 5 years0.72x
Sales to cash flow13.97x
Statement figures
Net sales (TTM)Rs 511 Cr
Net sales (latest year)Rs 503 Cr
Sales (latest quarter)Rs 103 Cr
Operating profit excl. other income (latest year)Rs 76 Cr
Operating profit (latest quarter)Rs 6 Cr
Other income (TTM)Rs 6 Cr
EBITDA (TTM)Rs 80 Cr
PBDT (TTM)Rs 79 Cr
Profit before tax (TTM)Rs 73 Cr
Tax (latest year)Rs 20 Cr
Net profit (TTM)Rs 54 Cr
Net profit (latest year)Rs 58 Cr
Net profit (latest quarter)Rs 4 Cr
Depreciation (TTM)Rs 7 Cr
Depreciation (latest quarter)Rs 2 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 260 Cr
Total expenditure (latest year)Rs 427 Cr
Total income (latest year)Rs 511 Cr
Share capitalRs 3 Cr
ReservesRs 367 Cr
Shareholders' fundsRs 370 Cr
Total assetsRs 509 Cr
Net blockRs 51 Cr
Capital work in progressRs 106 Cr
InvestmentsRs 3 Cr
ReceivablesRs 61 Cr
InventoryRs 37 Cr
Other liabilitiesRs 137 Cr
Shares outstanding (crore)2.89
Ownership
Promoter holding46.52% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 27.5 is at the 7th percentile of its own 9.4-year range (median 40.5, low 24.8, high 81.7).
P/B 4.01 is at the 1th percentile (median 7.03).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
PeriodAMRUTANJANNifty 50Difference
1 week+0.6%-2.8% +3.4 pts
1 month+3.0%-6.8% +9.8 pts
3 months-4.7%-7.6% +2.9 pts
6 months+4.0%+0.4% +3.6 pts
1 year-30.5%-9.9% -20.6 pts
2 years-35.2%-13.6% -21.6 pts
3 years-16.7%+14.2% -30.9 pts
5 years-37.5%+27.9% -65.4 pts
7 mutual fund schemes hold about ₹85 Cr. Over three months 6 bought more and 1 sold (share counts, price move removed).
FundWeightEst. Cr3m shares
ICICI Pru FMCG Fund2.16%35 +13%
ICICI Pru FMCG Fund2.16%34 +13%
iSIF Equity Long-Short Fund1.53%6 +100%
ICICI Pru Conservative Hybrid Fund0.10%3 +100%
ICICI Pru Balanced Hybrid Fund1.28%3 +100%
ICICI Pru Quant Fund1.39%2 +100%
DSP Small Cap Fund0.01%2 -97%

Red flags

F-score 5 of 8
lookRegulator order or action Regulator order or action 2026-08-01: Amrutanjan Health Care Limited has informed the Exchange about Action(s) taken or orders passed
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹103 Cr +9.5% vs Jun 2025. Net profit ₹4 Cr -47.4%.
Against our estimate for Jun 2026: sales -2.9%, profit -63.6% big miss. Our estimate for Sep 2026: sales Rs 130 Cr, profit Rs 15 Cr (how).

Activity

Compare
CompanyMcap (Cr)P/EROCE
Sun Pharmaceutical Industries Ltd447,47635.420.5 %
Divis Laboratories Ltd250,36384.022.0 %
Torrent Pharmaceuticals Ltd186,15283.415.2 %
Zydus Lifesciences Ltd119,75024.621.1 %
Cipla Ltd111,43031.115.5 %
Laurus Labs Ltd106,92897.817.8 %
Mankind Pharma Ltd105,12049.313.5 %
Dr Reddys Laboratories Ltd104,49432.413.0 %
Aurobindo Pharma Ltd97,68225.812.9 %
Lupin Ltd93,84015.829.9 %
Glenmark Pharmaceuticals Ltd68,90522.139.8 %
Alkem Laboratories Ltd62,77227.621.2 %
Biocon Ltd61,43984.53.61 %
Abbott India Ltd57,94935.944.8 %
Gland Pharma Ltd49,33343.115.1 %
No bulk or block deals on record.
Ex-dateActionFactor
2026-09-11Dividend - Rs 2.90 Per Share
2026-02-06Interim Dividend - Re 1 Per Share
2025-11-18Interim Dividend - Re 1 Per Share
2025-09-16Dividend - Rs 2.60 Per Share
2025-02-18Interim Dividend - Re 1 Per Share
2024-11-22Interim Dividend - Re 1 Per Share
2024-09-13Dividend - Rs 2.60 Per Share
2024-09-13Annual General Meeting
2024-02-20Interim Dividend - Re 1 Per Share
2023-11-23Interim Dividend - Rs 1 Per Share
2023-09-14Annual General Meeting/Dividend - Rs 2.60 Per Share
2023-07-13Buy Back
2023-02-24Interim Dividend - Re 1 Per Share
2022-11-14Interim Dividend - Re 1 Per Share
2022-09-14Annual General Meeting/Dividend - Rs 2.60 Per Share
2022-02-18Interim Dividend - Re 1 Per Share
2021-11-16 Interim Dividend - Re 1 Per Share
2021-09-15 Annual General Meeting/Dividend - Rs 2.60 Per Share
2021-02-17 Interim Dividend - Rs 0.80 Per Share
2020-11-19 Interim Dividend - Rs 0.80 Per Share
2020-09-15 Annual General Meeting
2020-02-18 Interim Dividend - Re 1.55 Per Share
2019-11-15 Interim Dividend - Rs 0.55 Per Share
2019-09-17 Dividend - Rs 1.05 Per Share
2019-02-20 Interim Dividend - Re 0.55 Per Share
2018-11-12 Interim Dividend - Re 0.55 Per Sh
2018-09-07 Annual General Meeting/Dividend Re 0.85 Per Share
2018-04-13 Face Value Split (Sub-Division) - From Rs 2/- Per Share To Re 1/- Per Share0.5000
2018-02-22 Interim Dividend - Rs 1.10 Per Share
2017-11-16 Interim Dividend - Rs 1.10 Per Share (Purpose Revised)
2017-09-13 Annual General Meeting/Dividend - Rs 1.65 Per Share
2017-02-16 Interim Dividend Rs 1.10 Per Share (Purpose Revised)
2016-11-17 Interim Dividend Rs 1.10 Per Share (Purpose Revised)
2016-09-14 Annual General Meeting
2016-03-18 Interim Dividend - Rs 2.65/- Per Share (Purpose Revised)
2016-02-17 Interim Dividend Rs.1.20 Per Share (Purpose Revised)
2015-09-10 Annual General Meeting/ Dividend - Rs 2.40/- Per Share
2015-02-13Interim Dividend - Re 1.10/- Per Share
2014-09-17Annual General Meeting / Dividend - Rs 2.20/- Per Share
2014-02-17Interim Dividend Re 1/- Per Share
2013-08-02Annual General Meeting/ Div Of Rs.2/- Per Equity Share
2013-02-21Interim Dividend Of Re. 1/- Per Share
2012-10-25Face Value Split From Rs. 10 To Rs. 2/-0.2000
2012-09-20Annual General Meeting / Div Of Rs. 10/- Per Equity Share
2012-02-23Interim Dividend Of Rs.5/- Per Share (50%)
2011-09-12Annual General Meeting/Fin.Div.Rs.10/- Per Share
2011-02-21Interim Dividend Rs.5/- Per Share
2010-08-13Annual General Meeting And Final Dividend Rs.10/- Per Share
2010-02-09Int Div-Rs.5/- Per Share
DateTypeWhat it says
2026-09-24Shareholder meetingVoting results.
2026-09-23Shareholder meetingProceedings of Annual General Meeting held on September 23, 2026
2026-08-28UpdatesBRSR for the FY 2025-26.
2026-08-28Shareholder meetingNotice of Annual General Meeting to be held on September 23, 2026
2026-08-12Investor PresentationInvestor Presentation
2026-08-11Record DateRecord date for the purpose of Dividend & Meeting is 11-Sep-2026.
2026-08-11Board meeting outcomeAmrutanjan Health Care Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
2026-08-05Commencement of commercial pCommencement of commercial production/operations
2026-08-05Credit RatingCredit Rating
2026-08-01Regulatory actionAction(s) taken or orders passed
2026-06-19General UpdatesOutcome of Postal Ballot
2026-06-19Shareholder meetingVoting results.
2026-06-15Disclosure under SEBI TakeovNageswaramma Private Trust has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Su...
2026-06-15Disclosure under SEBI TakeovAmulya Kamakshi Priya Arikirevula has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of In...
2026-06-15Disclosure under SEBI TakeovRamaa Prabhakar Arikirevula has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (S...
2026-05-27UpdatesReconstitution Of Committees Of Board Of Directors.
2026-05-26Director changeChange in Director(s) of the company.
2026-05-19Shareholder meetingNotice of Postal Ballot
2026-05-18Shareholder meetingNotice of Postal Ballot
2026-05-13UpdatesFinancial Results-Machine Readable Format.
2026-05-09Investor PresentationInvestor Presentation
2026-05-08UpdatesIntimation on rolling out of the revised Second Phase ESOP 2 of the existing ESOPScheme of the company by the name of Amrutanjan Health Care Limite...
2026-05-08AppointmentAppointment of Mr. Ramaswami Krishnan as Non- Executive Independent Director of the company w.e.f. May 08, 2026.
2026-05-08AppointmentRe-appointment of Mr. Muralidharan Swayambunathan as Non- Executive Independent Director of the company w.e.f. June 29, 2026.
2026-05-08AppointmentAppointment of Mr. Ramaswami Krishnan as Non- Executive Independent Director of the company w.e.f. May 08, 2026.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Amrutanjan Health Care Ltd?

Amrutanjan Health Care Ltd (AMRUTANJAN) has a market capitalisation of Rs 1,465 Cr. at the 2026-10-01 close.

What is the P/E ratio of Amrutanjan Health Care Ltd?

Amrutanjan Health Care Ltd trades at a P/E of 23.6 on trailing twelve-month profit, at the 2026-10-01 close.

What were Amrutanjan Health Care Ltd's latest quarterly results?

In the Jun 2026 quarter, Amrutanjan Health Care Ltd sales was Rs 103 Cr (+9.5% vs Jun 2025) and net profit was Rs 4 Cr.

What is the 52-week high and low of Amrutanjan Health Care Ltd?

The 52-week high is Rs 760.15 and the 52-week low is Rs 476.50.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03